Ipca Laboratories Q1 Results: Earnings call scheduled for Aug 14, 2026
Ipca Laboratories Limited has announced a Q1FY27 earnings conference call scheduled for Friday, August 14, 2026, from 15:30 hrs to 16:30 hrs IST. The call will be hosted by Dam Capital Advisors Ltd. and will feature Managing Director Mr. A K Jain and Corporate Counsel & Company Secretary Mr. Harish Kamath. The Q1FY27 financial results are set to be announced on Thursday, August 13, 2026, a day prior to the call. The announcement was filed on August 6, 2026, in compliance with SEBI (LODR) Regulations, 2015.
*this image is generated using AI for illustrative purposes only.
Ipca Laboratories Limited has scheduled a conference call for investors and analysts to discuss its Q1FY27 earnings and business update. The call is set for Friday, August 14, 2026, from 15:30 hrs to 16:30 hrs IST, a day after the company is slated to announce its Q1FY27 financial results on Thursday, August 13, 2026.
Earnings Call Details
The conference call will be hosted by Dam Capital Advisors Ltd. (formerly IDFC Securities Ltd.). Ipca Laboratories management will be represented by the following officials:
- Mr. A K Jain – Managing Director
- Mr. Harish Kamath – Corporate Counsel & Company Secretary
The details of the conference call are summarised below:
| Parameter: | Details |
|---|---|
| Date: | Friday, August 14, 2026 |
| Time: | 15:30 hrs to 16:30 hrs IST |
| Universal Access Numbers: | +91-22-6280 1384 / +91-22-7115 8285 |
| Hosted By: | Dam Capital Advisors Ltd. |
| Results Announcement Date: | Thursday, August 13, 2026 |
Participants are advised to dial in at least 5–10 minutes prior to the scheduled start time to ensure timely connection to the call.
Contact Information
For further information regarding the earnings call, participants may reach out to the following contacts:
| Contact: | Details |
|---|---|
| Name: | Anusha Kawthankar, Ipca Laboratories Limited |
| Tel: | +91-22-6210 6051 |
| Email: | anusha.kawthankar@ipca.com |
| Name: | Nitin Agarwal, Dam Capital Advisors Ltd. |
| Tel: | +91-22-42022568 |
| Email: | nitin.a@damcapital.in |
The announcement was made in accordance with Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and was filed on August 6, 2026. The filing was signed by Harish P. Kamath, Corporate Counsel & Company Secretary (ACS 6792), on behalf of Ipca Laboratories Limited.
Historical Stock Returns for IPCA Laboratories
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -3.72% | -0.27% | -5.14% | +16.43% | +26.74% | +45.00% |
How might Ipca Laboratories' Q1FY27 performance in key therapeutic areas like oncology and anti-infectives influence its valuation multiples compared to peers?
What specific guidance or commentary from MD A K Jain during the call could signal shifts in the company's capital allocation strategy for FY27?
Could regulatory updates or supply chain dynamics discussed in the business update impact Ipca's export margins in critical markets like the US and Europe?
16
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
